About Renaissance Fusion Renaissance Fusion is developing key technologies for future fusion reactors, including next-generation High-Temperature Superconducting (HTS) materials and magnets, liquid-metal technologies, and modular stellarator systems. Our team is international, diverse, agile, and based in
Quobly aims to have a strong impact on society by providing cost-competitive universal quantum processors to solve currently intractable problems. Founded in 2022, Quobly is a fast-growing start-up located in Grenoble’s vibrant and multidisciplinary ecosystem. The
Job Description Summary Job Description Role Summary/Purpose: L’Ingénieur Projet eBoP est responsable des études de conception, de dimensionnement, de performance et de conformité des systèmes électriques courant continu et basse tension, dans le cadre de projets
These are exciting times at EMBL Grenoble. To support our growing activities, we are looking to strengthen our Instrumentation Team with an enthusiastic and skilled Mechatronics Engineer. The Instrumentation Team (https://www.embl.org/groups/papp/ ) develops high-precision instruments for
The European Molecular Biology Laboratory (EMBL) is one of the highest-ranked scientific research organisations in the world. The Headquarters Laboratory is located in Heidelberg (Germany) and further Units are situated Grenoble (France), Hamburg (Germany), Hinxton (UK),
General information Organisation The French Alternative Energies and Atomic Energy Commission (CEA) is a key player in research, development and innovation in four main areas : • defence and security, • nuclear energy (fission and fusion),
When the quantum engineering technology meets the real word impact. Based in the heart of the French Alps, Quobly is the result of more than 15 years of research into quantum computing. At Quobly we made
THE COMPANY Global Leader in Medical Device Innovation A pioneering MedTech company developing innovative implantable technologies that are transforming the treatment of urological disorders. With a presence across multiple continents, they are committed to advancing clinical